BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31096089)

  • 1. DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy.
    Masoudi-Sobhanzadeh Y; Omidi Y; Amanlou M; Masoudi-Nejad A
    Comput Biol Med; 2019 Jun; 109():254-262. PubMed ID: 31096089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm.
    Masoudi-Sobhanzadeh Y; Masoudi-Nejad A
    BMC Bioinformatics; 2020 Jul; 21(1):313. PubMed ID: 32677879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug databases and their contributions to drug repurposing.
    Masoudi-Sobhanzadeh Y; Omidi Y; Amanlou M; Masoudi-Nejad A
    Genomics; 2020 Mar; 112(2):1087-1095. PubMed ID: 31226485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.
    Moosavinasab S; Patterson J; Strouse R; Rastegar-Mojarad M; Regan K; Payne PR; Huang Y; Lin SM
    Database (Oxford); 2016; 2016():. PubMed ID: 27189611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repurposing with network reinforcement.
    Nam Y; Kim M; Chang HS; Shin H
    BMC Bioinformatics; 2019 Jul; 20(Suppl 13):383. PubMed ID: 31337333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
    Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
    BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Drug-Target Network-Based Supervised Machine Learning Repurposing Method Allowing the Use of Multiple Heterogeneous Information Sources.
    Nascimento ACA; Prudêncio RBC; Costa IG
    Methods Mol Biol; 2019; 1903():281-289. PubMed ID: 30547449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DrugBank 5.0: a major update to the DrugBank database for 2018.
    Wishart DS; Feunang YD; Guo AC; Lo EJ; Marcu A; Grant JR; Sajed T; Johnson D; Li C; Sayeeda Z; Assempour N; Iynkkaran I; Liu Y; Maciejewski A; Gale N; Wilson A; Chin L; Cummings R; Le D; Pon A; Knox C; Wilson M
    Nucleic Acids Res; 2018 Jan; 46(D1):D1074-D1082. PubMed ID: 29126136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy.
    Sivapalarajah S; Krishnakumar M; Bickerstaffe H; Chan Y; Clarkson J; Hampden-Martin A; Mirza A; Tanti M; Marson A; Pirmohamed M; Mirza N
    Epilepsia; 2018 Feb; 59(2):492-501. PubMed ID: 29341109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EK-DRD: A Comprehensive Database for Drug Repositioning Inspired by Experimental Knowledge.
    Zhao C; Dai X; Li Y; Guo Q; Zhang J; Zhang X; Wang L
    J Chem Inf Model; 2019 Sep; 59(9):3619-3624. PubMed ID: 31433187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing from the perspective of pharmaceutical companies.
    Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
    Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Drug Repurposing: Classification of the Research Opportunities and Challenges.
    Sadeghi SS; Keyvanpour MR
    Curr Comput Aided Drug Des; 2020; 16(4):354-364. PubMed ID: 31198115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new computational drug repurposing method using established disease-drug pair knowledge.
    Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
    Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
    Guney E
    Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BalestraWeb: efficient online evaluation of drug-target interactions.
    Cobanoglu MC; Oltvai ZN; Taylor DL; Bahar I
    Bioinformatics; 2015 Jan; 31(1):131-3. PubMed ID: 25192741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.